Orbimed Advisors SC 13D/A Turning Point Therapeutics / ORBIMED ADVISORS ownership change

Exhibit 1

JOINT FILING AGREEMENT

 The undersigned hereby agree that the Amendment No. 1 to Schedule 13D, dated May 22, 2020, with respect to the ordinary shares of Turning Point Therapeutics, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 22^nd day of May 2020.

ORBIMED ADVISORS LLC
By:	/s/ Jonathan Silverstein
	Name: Jonathan Silverstein
	Title: Member
ORBIMED CAPITAL GP VI LLC
By:	ORBIMED ADVISORS LLC, its managing member
By:	/s/ Jonathan Silverstein
	Jonathan Silverstein
	Title: Member of OrbiMed Advisors LLC
ORBIMED CAPITAL LLC
By:	/s/ Jonathan Silverstein
	Jonathan Silverstein
	Title: Member